Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

The introduction of immune checkpoint inhibitors (ICIs) has represented a major therapeutic breakthrough for patients with mismatch repair-deficient (MMRd) endometrial cancer (EC). However, despite initial clinical success, a considerable subset of patients does not experience meaningful clinical be...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Medical Oncology
Main Authors:	Juan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie, Félix Blanc-Durand, Audrey Le Formal, Étienne Rouleau, Alexandra Leary
Format:	Article
Language:	English
Published:	SAGE Publishing 2026-03-01
Online Access:	https://doi.org/10.1177/17588359261423888